Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Infectious Diseases
|
March 1, 1975
Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection
R T Steigbigel, R L Greenman, J S Remington
Antimicrobial Agents and Chemotherapy
|
January 1, 1984
Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers
R L Greenman, S M Arcey, D A Gutterman, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
May 2, 1998
Improved resolution and signal-to-noise ratio in MRI via enhanced signal digitization
M A Elliott, E K Insko, R L Greenman, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1981
Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid
G M Dickinson, D G Droller, R L Greenman, et al.
Magnetic Resonance in Medicine
|
May 15, 1998
Fast imaging of phosphocreatine using a RARE pulse sequence
R L Greenman, M A Elliott, K Vandenborne, et al.
Journal of Virology
|
November 1, 1973
DNA polymerase associated with human hepatitis B antigen
P M Kaplan, R L Greenman, J L Gerin, et al.
Southern Medical Journal
|
October 1, 1983
Toxoplasma encephalitis in recent Haitian entrants
J C Chan, L B Moskowitz, J Olivella, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 1985
Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation
R L Greenman, S M Arcey, G M Dickinson, et al.
JAMA
|
August 28, 1991
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group
R L Greenman, R M Schein, M A Martin, et al.
JAMA
|
June 15, 1994
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group
C J Fisher, J F Dhainaut, S M Opal, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Infectious Diseases
|
March 1, 1975
Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection
R T Steigbigel, R L Greenman, J S Remington
Antimicrobial Agents and Chemotherapy
|
January 1, 1984
Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers
R L Greenman, S M Arcey, D A Gutterman, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
May 2, 1998
Improved resolution and signal-to-noise ratio in MRI via enhanced signal digitization
M A Elliott, E K Insko, R L Greenman, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1981
Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid
G M Dickinson, D G Droller, R L Greenman, et al.
Magnetic Resonance in Medicine
|
May 15, 1998
Fast imaging of phosphocreatine using a RARE pulse sequence
R L Greenman, M A Elliott, K Vandenborne, et al.
Journal of Virology
|
November 1, 1973
DNA polymerase associated with human hepatitis B antigen
P M Kaplan, R L Greenman, J L Gerin, et al.
Southern Medical Journal
|
October 1, 1983
Toxoplasma encephalitis in recent Haitian entrants
J C Chan, L B Moskowitz, J Olivella, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 1985
Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation
R L Greenman, S M Arcey, G M Dickinson, et al.
JAMA
|
August 28, 1991
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group
R L Greenman, R M Schein, M A Martin, et al.
JAMA
|
June 15, 1994
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group
C J Fisher, J F Dhainaut, S M Opal, et al.
Page
of 2